It is a world-first that pure semaglutide processed with DehydraTECH technology without SNAC will be compared directly to SNAC-enabled Rybelsus® in a multiple week human study. Is DehydraTECH ...

RANI READ THE FULL RANI RESEARCH REPORT On February 5 th , Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...

drug absent the SNAC formulation used in the Rybelsus semaglutide composition from the first two human pilot studies. Arm 1 – DehydraTECH-CBD capsules Arm 2 – DehydraTECH-semaglutide capsules ...

The type 2 diabetes medication, generically known as semaglutide, has received unprecedented attention in the press and the medical community for its ability to trigger profound weight loss.